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Background
The aim of the present study was to investigate the
cytokine genetic profile in patients with severe asthma.
Method
The study population consisted of 52 patients, 30 with
allergic asthma, mean age 35,2±14,51 years (Group A),
22 patients with non-allergic asthma, mean age 47,1
±16,3 years (Group B) and 21 healthy controls, mean
age 36,6±10,5 years (Group C). 29 patients had mild, 10
moderate and 12 severe asthma. For the immunogenetic
study DNA was extracted from the patients’ peripheral
blood samples. Determination of gene polymorphisms
were performed by PCR using the INVITROGEN kit.
Results
Analysis of IL-1 polymorphisms and in particular IL-1b
(+3962) showed statistically significant differences between
Group A-B (p=0.029) and Group B-C (p=0.024) respec-
tively. Analysis of IL4 -1098 polymorphisms showed an
increased frequency of guanine in Group A (p=0.036)
when compared to Group C whereas for IL4 -590, CC
genotype showed an increased frequency in Group C and
C/T in Group A (p=0.003), suggesting possible association
between thymine and risk of asthma development. Regard-
ing IL-10 the diplotype GCC/ACC was more frequent in
Group A when compared with Group (p=0,038). The
TGF-b1 diplotype CG/CC showed increased frequencies
in comparison with Group B and Group C (p=0,041 aι
p=0,012 aντίsτοιca). Analysis of TNFa-238 in G/G and
A/G genotypes showed statistically significant differences
between the Group A-C, (p=0.008) and Group B-C
(p=0.001). G/G showed an increased frequency in Group
C and A/G in Groups A and B. Besides, analysis of IFN-g
showed that the AA genotype was associated with Group
C whereas the genotype AT was associated with risk of
development of non allergic asthma (p=0,006). Regarding
asthma severity, severe asthma compared with mild
asthma, was associated with the genotype C/T of IL-1a
and IL1b+3962 (p=0.019 aι p=0.025 respectively), with
the IL-4TTT/GCC diplotype, with the IL10GCC/ACC aι
IL10GCC/ATA diplotypes (p=0.045) and with the IL-
12AC genotype ((p=0.046).
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